Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting
-
Newly Announced Royalton Chic Barbados to Join Marriott’s Autograph Collection Portfolio
-
Digital Express Announces Acquisition of Canon varioPRINT iX Inkjet Press
-
Crown Announces Suspension of Equity Line of Credit
-
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
-
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920
-
BILD Urges Comprehensive Solutions To Address Cost to Build Crisis in Toronto
-
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
-
Malizia-Seaexplorer competing in Vendée Globe under Monaco flag
-
Healthcare Integrated Technologies, Inc. Appoints Caleb Dixon as Chief Customer Officer
-
TScan Therapeutics Announces Upcoming Oral Presentation of Data from the ALLOHA™ Phase 1 Heme Trial at the 66th American Society of Hematology Annual Meeting and Exposition
-
Discover Fatboy’s Ultimate Holiday Gift Guide: Unique & Playful Gifts for Every Home in Canada
-
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
-
Celebrity Dog “Swaggy Wolfdog” Refuses Candidate Endorsement, Launches Petition to End Pet Fees for Renters
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
Allogene Therapeutics to Present New Data Demonstrating the Potential of ALLO-316 in Heavily Pretreated Adult Patients with CD70 Positive Advanced Renal Cell Carcinoma (RCC) at the International Kidne
-
Legend Biotech to Unveil Minimal Residual Disease Data from Landmark CARTITUDE-4 Trial in Multiple Myeloma
-
Kura Oncology to Present Updated Data from KOMET-007 Combination Trial of Ziftomenib at ASH Annual Meeting
-
AQUALAB Launches SKALA Dry
-
METAGENOMI (NASDAQ: MGX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
-
Umoja Biopharma Announces Oral and Poster Presentations at the 66th American Society of Hematology Annual Meeting
-
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
-
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Honouring Veterans Through Second Careers During Veterans' Week
-
SAGA Metals Corp. Completes Second & Final Tranche of IPO Prospectus Offering
-
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Ann
-
Nouscom’s Off-the-Shelf Neoantigen Immunotherapy, NOUS-209, Continues to Elicit Potent and Durable Immune Responses in Lynch Syndrome Carriers Highlighting its Potential to ‘Intercept’ Cancer
-
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma
-
Revolution Medicines to Participate in Upcoming Investor Conferences
-
Innovative Food Holdings, Inc. Announces Q3 2024 Earnings Call
-
UFP Technologies Announces Record Q3 2024 Results
-
Free Gold IRA Kit Now Available For Download
-
Nomad The Label US Announces Launch of Luxurious Linen Clothing Collection
-
MKS Instruments Declares Quarterly Cash Dividend
-
Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting
-
Tessera Therapeutics to Present New Preclinical Data From In Vivo Programs for Sickle Cell Disease and T-Cell Therapies at the 66th American Society of Hematology Annual Meeting
-
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting
-
Capricor Therapeutics to Present Third Quarter 2024 Financial Results and Recent Corporate Update on November 13
-
America’s Car-Mart, Inc. Schedules Second Quarter Fiscal Year 2025 Results and Conference Call
-
Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition
-
Tenstorrent Expands Deployment of Arteris’ Network-on-Chip IP to Next-Generation of Chiplet-Based AI Solutions
-
Electromagnetic Survey Identifies Multiple Strong Targets Coincident with Elevated Gold and Silver at Star River
-
MKS Instruments Announces Appointment of Wissam Jabre to its Board of Directors
-
Outpace Bio to present new data on programmed CAR T cell candidate OPB-101 at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
Ichnos Glenmark Innovation (IGI) Announces First Presentation of Data from Phase 1 Study of the Trispecific ISB 2001 in Relapsed/Refractory Multiple Myeloma (r/rMM) at Upcoming ASH Annual Meeting
-
SectorNet and Carahsoft Partner to Deliver Secure Collaboration Solutions to the Public Sector
-
IN8bio Announces Upcoming Presentation at the 2024 American Society of Hematology (ASH) Annual Meeting
-
Ivans Index October 2024 Results Released
-
Affimed Announces Acceptance of Three Abstracts at the 2024 ASH Annual Meeting Including an Oral Presentation Underscoring Advancing Clinical Pipeline in Leukemia and Lymphoma
